EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $264,000 | +8.2% | 13,446 | -2.5% | 0.00% | +33.3% |
Q3 2018 | $244,000 | -3.9% | 13,791 | +16.7% | 0.00% | -25.0% |
Q2 2018 | $254,000 | -96.3% | 11,818 | -96.2% | 0.00% | -96.2% |
Q1 2018 | $6,806,000 | -36.5% | 307,275 | -12.8% | 0.10% | -32.9% |
Q4 2017 | $10,716,000 | +55.4% | 352,508 | +23.9% | 0.16% | +58.2% |
Q3 2017 | $6,896,000 | -5.1% | 284,588 | -3.6% | 0.10% | -10.9% |
Q2 2017 | $7,270,000 | -39.6% | 295,175 | -46.9% | 0.11% | -46.1% |
Q1 2017 | $12,037,000 | +73.9% | 555,458 | +19.7% | 0.20% | +52.2% |
Q4 2016 | $6,922,000 | +20.3% | 464,228 | +3.2% | 0.13% | +32.7% |
Q3 2016 | $5,756,000 | – | 450,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |